Syra Health Corp (NASDAQ:SYRA) shares, rose in value on Friday, February 14, with price down by -7.49% to the previous day’s close as strong demand from buyers drove the stock to $0.41.
Actively observing the price movement in the last trading, the stock closed the session at $0.44, falling within a range of $0.407 and $0.45. Referring to stock’s 52-week performance, its high was $3.28, and the low was $0.34. On the whole, SYRA has fluctuated by -17.17% over the past month.
With the market capitalization of Syra Health Corp currently standing at about $4.98 million, investors are eagerly awaiting this quarter’s results, scheduled for in March.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 7.99M, with a low estimate of 2.01M and a high estimate of 2.01M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 2.01M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SYRA’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of SYRA currently trading nearly -10.57% and -8.76% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 44.79, while the 7-day volatility ratio is showing 12.53% which for the 30-day chart, stands at 14.06%. Furthermore, Syra Health Corp (SYRA)’s beta value is 4.22, and its average true range (ATR) is 0.07.
A comparison of Syra Health Corp (SYRA) with its peers suggests the former has fared considerably weaker in the market. SYRA showed an intraday change of -7.49% in last session, and over the past year, it shrunk by -85.76%%.
Data on historical trading for Syra Health Corp (NASDAQ:SYRA) indicates that the trading volumes over the past 10 days have averaged 2.48 and over the past 3 months, they’ve averaged 2.12 million. According to company’s latest data on outstanding shares, there are 8.97 million shares outstanding.
Nearly 24.08% of Syra Health Corp’s shares belong to company insiders and institutional investors own 6.06% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.46 million shares as on 2025-01-31, resulting in a short ratio of 0.1. According to the data, the short interest in Syra Health Corp (SYRA) stood at 618.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 0.12 million. The stock has fallen by -0.46% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SYRA stock heading into the next quarter.
